| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,137 |
12,874 |
$2.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,826 |
6,707 |
$1.34M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,632 |
2,604 |
$313K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,248 |
1,231 |
$260K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,765 |
3,710 |
$236K |
| 80053 |
Comprehensive metabolic panel |
5,152 |
5,021 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,479 |
5,375 |
$30K |
| 80061 |
Lipid panel |
2,060 |
2,036 |
$26K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
125 |
123 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
211 |
205 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,678 |
2,620 |
$17K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
549 |
537 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
304 |
302 |
$12K |
| G0378 |
Hospital observation service, per hour |
15 |
13 |
$11K |
| 86780 |
|
595 |
572 |
$9K |
| 86803 |
|
432 |
425 |
$8K |
| 80050 |
General health panel |
190 |
188 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
222 |
110 |
$7K |
| 87340 |
|
472 |
465 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
521 |
383 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
260 |
259 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
240 |
238 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
240 |
238 |
$6K |
| 81001 |
|
1,988 |
1,964 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
104 |
104 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
230 |
225 |
$4K |
| 83690 |
|
822 |
811 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
260 |
259 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
327 |
322 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
452 |
441 |
$3K |
| 83735 |
|
413 |
405 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
58 |
56 |
$2K |
| 82607 |
|
189 |
183 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
203 |
200 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
219 |
218 |
$1K |
| 84439 |
|
127 |
125 |
$901.11 |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$813.76 |
| 82550 |
|
139 |
136 |
$645.32 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
35 |
33 |
$617.00 |
| 82728 |
|
58 |
57 |
$484.77 |
| 84484 |
|
53 |
49 |
$428.15 |
| 83695 |
|
26 |
26 |
$247.25 |
| 73630 |
|
18 |
14 |
$235.40 |
| 84550 |
|
53 |
53 |
$198.88 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
24 |
24 |
$194.40 |
| 86592 |
|
39 |
39 |
$187.20 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$183.05 |
| 82043 |
|
30 |
30 |
$172.23 |
| 82570 |
|
30 |
30 |
$153.91 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$86.40 |
| 83540 |
|
13 |
13 |
$65.44 |
| 83550 |
|
13 |
13 |
$38.73 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,902 |
3,463 |
$4.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,472 |
1,284 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
2,218 |
1,277 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
445 |
283 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
629 |
575 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
743 |
629 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
364 |
344 |
$0.00 |
| J3490 |
Unclassified drugs |
152 |
105 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
388 |
364 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
37 |
37 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
70 |
62 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
343 |
302 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
129 |
105 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
73 |
69 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
586 |
504 |
$0.00 |
| 90715 |
|
49 |
39 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
1,262 |
561 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,406 |
2,028 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
77 |
69 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
187 |
179 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
295 |
234 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
177 |
163 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
179 |
166 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
34 |
32 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
26 |
25 |
$0.00 |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
12 |
12 |
$0.00 |